THERACLION (ALTHE.PA) Stock Price, Forecast & Analysis

EPA:ALTHE • FR0010120402

0.63 EUR
0 (0%)
Last: Feb 24, 2026, 07:00 PM

ALTHE.PA Key Statistics, Chart & Performance

Key Statistics
Market Cap36.66M
Revenue(TTM)1.90M
Net Income(TTM)-5.25M
Shares58.19M
Float28.92M
52 Week High1.25
52 Week Low0.14
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.11
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2014-04-25
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
ALTHE.PA short term performance overview.The bars show the price performance of ALTHE.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

ALTHE.PA long term performance overview.The bars show the price performance of ALTHE.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 100 150 200

The current stock price of ALTHE.PA is 0.63 EUR. In the past month the price decreased by -17.53%. In the past year, price increased by 215.18%.

THERACLION / ALTHE Daily stock chart

ALTHE.PA Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ALTHE.PA. When comparing the yearly performance of all stocks, ALTHE.PA is one of the better performing stocks in the market, outperforming 98.5% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
ALTHE.PA Full Technical Analysis Report

ALTHE.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ALTHE.PA. Both the profitability and financial health of ALTHE.PA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ALTHE.PA Full Fundamental Analysis Report

ALTHE.PA Financial Highlights

Over the last trailing twelve months ALTHE.PA reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS decreased by -16.67% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -45.47%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%17.72%
Sales Q2Q%449.83%
EPS 1Y (TTM)-16.67%
Revenue 1Y (TTM)215.63%
ALTHE.PA financials

ALTHE.PA Forecast & Estimates


Analysts
Analysts86.67
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
ALTHE.PA Analyst EstimatesALTHE.PA Analyst Ratings

ALTHE.PA Ownership

Ownership
Inst OwnersN/A
Ins Owners15.13%
Short Float %N/A
Short RatioN/A
ALTHE.PA Ownership

ALTHE.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
1MDT MEDTRONIC PLC16.09108.279B
2M6 MEDTRONIC PLC15.91107.061B
SHL SIEMENS HEALTHINEERS AG15.746.868B
PHIA KONINKLIJKE PHILIPS NV17.4825.344B
PHI1 KONINKLIJKE PHILIPS NV17.2825.315B
BIM BIOMERIEUX19.0811.209B
DIA DIASORIN SPA17.123.929B
OBCK OTTOBOCK SE & CO KGAA18.33.599B
AFX CARL ZEISS MEDITEC AG - BR11.22.372B
1AFX CARL ZEISS MEDITEC AG - BR10.942.309B

About ALTHE.PA

Company Profile

ALTHE logo image Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France and currently employs 33 full-time employees. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.

Company Info

THERACLION

244, avenue Pierre Brossolette

Malakoff ILE-DE-FRANCE FR

Employees: 32

ALTHE Company Website

ALTHE Investor Relations

Phone: 33155489070

THERACLION / ALTHE.PA FAQ

What does ALTHE do?

Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France and currently employs 33 full-time employees. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.


What is the current price of ALTHE stock?

The current stock price of ALTHE.PA is 0.63 EUR.


Does ALTHE stock pay dividends?

ALTHE.PA does not pay a dividend.


What is the ChartMill rating of THERACLION stock?

ALTHE.PA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Is THERACLION (ALTHE.PA) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALTHE.PA.


What is the employee count for ALTHE stock?

THERACLION (ALTHE.PA) currently has 32 employees.


Can you provide the ownership details for ALTHE stock?

You can find the ownership structure of THERACLION (ALTHE.PA) on the Ownership tab.